StockWatch
·

Protean eGov Technologies Ltd

BSE: 544021

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
266.07
-18.0%+11.5%
Expenditure
258.31
-13.4%+26.9%
Net Profit
5.98
-70.0%-77.4%
OPM %
4.84%
-3.41pp-4.10pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0090.87181.74272.61363.48Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Protean eGov Q1 FY27: revenue up 19% YoY but consolidated PAT sinks 75% on margin squeeze

it services · e-governance · margin compression

ResultsQ1 FY2705 Aug 20263 minTechnology / IT
Latest
Auditor4 Aug, 3:57 pm

Protean eGov Q1 FY27: revenue up 19% YoY but consolidated PAT sinks 75% on margin squeeze

Protean eGov's consolidated Q1 FY27 revenue rose 19.0% YoY to ₹250.96 Cr (from ₹210.84 Cr in Q1 FY26), consistent with management's own release, but consolidated PAT fell 75.4% YoY to ₹5.86 Cr (from ₹23.85 Cr) and 80.7% QoQ (from ₹30.38 Cr in Q4 FY26). About ₹5.76 Cr of the year-ago PAT base came from a one-off write-back of employee-benefit provisions sitting in other income; stripping that out, adjusted YoY PAT decline is still steep at roughly 70%, so this is not primarily a base-effect story — revenue growth did not translate into profit growth. Standalone PAT of ₹5.98 Cr (EPS ₹1.47) tracked closely with consolidated PAT of ₹5.86 Cr (EPS ₹1.44), so both bases tell the same story. The compression sits on the operating line: consolidated operating (EBITDA-level) margin fell to roughly 4.95% of revenue from operations, down from 7.78% a year ago and 12.11% last quarter, and net margin fell to 2.2% of total income from 9.96% YoY and 9.41% QoQ. Processing charges of ₹78.46 Cr (31.3% of revenue) and system implementation/support costs of ₹67.25 Cr both rose YoY and stayed elevated sequentially, and total expenses grew roughly 25% YoY against 19% revenue growth. Other income also fell to ₹15.40 Cr from ₹28.52 Cr a year ago — partly the provision write-back rolling off, partly a genuine YoY decline in the base. No formal numeric guidance for FY27 is on record — management's Q4 FY26 call spoke qualitatively of "improving operating leverage" and scaling product-led/RFP businesses, with Aadhaar Seva Kendra revenue expected to ramp meaningfully around Q3 FY27. This quarter's margin trend runs opposite to that operating-leverage commentary, so on that specific marker the print reads as a miss rather than on-track. A web search turned up no specific street/consensus PAT estimate for this quarter to benchmark against, so vsStreet is unknown. Management's own release frames the quarter simply as "19% YoY revenue growth, PAT declines 75%" — the reported numbers support that framing without qualification. The quarter also carried two governance events: the board appointed Ajay Rajan as MD & CEO (effective mid-quarter, July 15) and approved T R Chadha & Co. LLP as statutory auditor for a five-year term from FY27, succeeding BSR & Associates at the end of its second term — neither is a direct driver of this quarter's numbers, but they form the leadership backdrop against which the next 1-2 quarters, including the flagged Q3 FY27 Aadhaar Seva Kendra ramp, will be watched.

4 Aug 2026, 03:57 pm

Corporate Events

DividendPROTEAN
2026
28Aug

₹10 / share

BSE Filing
Board MeetingPROTEAN
2026
4Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingPROTEAN
2026
20May

Board Meeting

The Board of Directors at their meeting held on May 20, 2026…

BSE Filing
DividendPROTEAN
2025
29Aug

₹10 / share

BSE Filing
Board MeetingPROTEAN
2025
30Jan

Board Meeting

Board Meeting intimation, Consider and approve Unaudited Fin…

BSE Filing
Board MeetingPROTEAN
2024
30Oct

Board Meeting

Consider and approve Unaudited Financial Results (Standalone…

BSE Filing
Board MeetingPROTEAN
2024
5Aug

Board Meeting

Board Meeting to consider Unaudited Financial Results (Stand…

BSE Filing
DividendPROTEAN
2024
31May

₹10 / share

BSE Filing
Board MeetingPROTEAN
2024
7May

Board Meeting

consider and approve Audited Financial Results (Standalone &…

BSE Filing